Sherri-AnnMaryna(Burnett)Burnett-BowieMDMPH

Diabetes, Lipid Metabolism

Assistant Professor of Medicine, Harvard Medical School & Massachusetts General Hospital

Dr. Burnett-Bowie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
15 Parkman St # 730a
Endocrine Associates
Boston, MA 02114
Phone+1 617-726-8720

Fax+1 617-724-2718

I am a board certified endocrinologist with a focus on mineral metabolism (osteoporosis, hyperparathyroidism, vitamin D deficiency, phosphate disorders). I completed clinical training at the University of Pittsburgh School of Medicine and Massachusetts General Hospital (for both internal medicine and endocrine fellowship).

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2003
Massachusetts General HospitalResidency, Internal Medicine, 1997 - 2000
University of Pittsburgh School of MedicineClass of 1997

Vitamin D Deficiency, Insulin Resistance and FGF-23 Start of enrollment: 2006 May 01
Completed
Not Applicable
Different Vitamin D Preparations & FGF23 in Humans Start of enrollment: 2009 May 01
Completed
Not Applicable
Vitamin D Deficiency in Adolescent Girls Start of enrollment: 2010 Sep 01
Completed
Not Applicable

PubMed

65 citations
Clinical Measures Identify Vitamin D Deficiency in Dialysis
Ishir Bhan, Sherri-Ann M. Burnett-Bowie, Jun Ye, Marcello Tonelli, Ravi Thadhani
Clinical Journal of the American Society of Nephrology. 2010-03-01
253 citations
Long-term follow-up of patients with hypoparathyroidism.
Deborah M. Mitchell, Susan Regan, Michael R. Cooley, Kelly Lauter, Michael C. Vrla
The Journal of Clinical Endocrinology and Metabolism. 2012-10-05
300 citations
Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
Joy N. Tsai, Alexander V. Uihlein, Hang Lee, Ruchit Kumbhani, Erica Siwila-Sackman
Lancet. 2013-07-06

Lectures

Fracture Risk Assessment Beyond BMD and FRAX
ENDO 2019 - New Orleans, LA - 3/23/2019
Climate Change: #TimesUp for Endocrinology
ENDO 2019 - New Orleans, LA - 3/23/2019

By the Numbers: How Menopause Affects Different DemographicsDecember 5th, 2022
Knowledge of Racism’s Impact on Health Is Key for Physicians to Intervene, Study FindsFebruary 14th, 2022
2010 Claflin Awards Support Six Women ResearchersFebruary 12th, 2016
Join now to see all

Dietary And Hormonal Regulation Of FGF-23 In HumansNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
Vitamin D Deficiency: Insulin Resistance And FGF-23National Center For Research Resources2007–2008
Effects Of Dietary Phosphate On The Regulation Of FGF-23National Center For Research Resources2005
Physiological Regulation Of FGF-23 By Dietary PhosphateNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004